While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimers disease, the extensive body of evidence supporting semaglutide continues to provide benefits for individuals with type 2 diabetes, obesity, and related comorbidities, Martin Holst Lange, chief scientific officer and executive vice president of research and development at Novo Nordisk, said in a statement

Consumers should be especially wary if a seller: Offers the drug without a prescription or licensed supervision Labels the product research-grade, for research use only or not approved for human use Sells it in unusual forms such as drops, sprays or skin patches rather than injectables Encourages buyers to mix, reconstitute or split doses on their own Promotes the product to minors Fails to include clear safety warnings or usage instructions Operates from another country or sells unusually large quantities Urges customers to falsify their weight or health status to obtain the drug Consumers can report unsafe or deceptive weight-loss drug offers to the NMDOJ Consumer Protection Division at nmdoj.gov/get-help/submit-a-complaint
PMC 5861502
L-carnitine and fat burn More than a supplement to burn fat , L-carnitine is a substance that optimizes the cellular energy function
Daily administration of SUN (25 mg/kg) for 28 days resulted in a significant 55% increase in malonyl-CoA level in rat heart tissues, as compared to the control group